Trevi Therapeutics
TRVI
#7259
Rank
C$0.52 B
Marketcap
$5.89
Share price
0.74%
Change (1 day)
219.38%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.42

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.45. In 2022 the company made an earnings per share (EPS) of -$0.81 an increase over its 2021 EPS that were of -$2.16.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.42-48.08%
2022-$0.81-62.67%
2021-$2.16-17.29%
2020-$2.6218.17%
2019-$2.21-46.21%
2018-$4.12